TARA ATTA

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease VERNON HILLS, IL NPI 1639166374

General Payments — all program years on this page

$3,838.57

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 146
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,076.03 across 36 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $1,076.0336

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $158.414
2019 $381.3810
2020 $156.749
2021 $724.8230
2022 $585.4924
2023 $755.7033
2024 $1,076.0336

Records — PY2024 (36)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086660047 Novartis Pharmaceuticals Corporation $19.27 02/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086660055 Novartis Pharmaceuticals Corporation $19.43 03/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086660057 Novartis Pharmaceuticals Corporation $18.15 04/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086660061 Novartis Pharmaceuticals Corporation $29.80 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086660065 Novartis Pharmaceuticals Corporation $19.80 05/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086660067 Novartis Pharmaceuticals Corporation $30.21 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086660069 Novartis Pharmaceuticals Corporation $21.52 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086660071 Novartis Pharmaceuticals Corporation $19.45 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086660073 Novartis Pharmaceuticals Corporation $21.95 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086660083 Novartis Pharmaceuticals Corporation $21.65 08/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086660085 Novartis Pharmaceuticals Corporation $16.74 09/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086660087 Novartis Pharmaceuticals Corporation $22.44 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086660089 Novartis Pharmaceuticals Corporation $22.72 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086660091 Novartis Pharmaceuticals Corporation $21.34 11/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096674581 Novo Nordisk Inc $8.58 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096888242 Novo Nordisk Inc $24.96 04/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097045268 Novo Nordisk Inc $24.60 09/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097107093 Novo Nordisk Inc $25.37 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097111034 Novo Nordisk Inc $116.58 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097116576 Novo Nordisk Inc $20.77 05/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097590503 Novo Nordisk Inc $25.93 11/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097825820 Novo Nordisk Inc $24.60 07/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101390634 E.R. Squibb & Sons, L.L.C. $14.37 01/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104379239 AstraZeneca Pharmaceuticals LP $19.18 01/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105360746 AstraZeneca Pharmaceuticals LP $14.63 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115431355 Amgen Inc. $139.81 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118089238 Boehringer Ingelheim Pharmaceuticals, Inc. $11.58 01/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118089240 Boehringer Ingelheim Pharmaceuticals, Inc. $16.65 12/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118089242 Boehringer Ingelheim Pharmaceuticals, Inc. $20.41 01/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118089244 Boehringer Ingelheim Pharmaceuticals, Inc. $25.00 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118089246 Boehringer Ingelheim Pharmaceuticals, Inc. $33.16 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118089248 Boehringer Ingelheim Pharmaceuticals, Inc. $33.40 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118089250 Boehringer Ingelheim Pharmaceuticals, Inc. $33.59 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119411358 Medtronic, Inc. $82.50 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135455251 Lilly USA, LLC $23.07 07/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154874482 Kiniksa Pharmaceuticals International, plc $32.82 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.